NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,942.78 mln
Float17.26 mln
Earnings Date05/07/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.56
Likely reliable
1-Year Forecast
78.92
Modest upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.38
Low leverage
Pre-Tax Margin
20.42%
Healthy margin
Business Description
AnaptysBio Inc. is a San Diego-based biotechnology company working to develop treatments for autoimmune and inflammatory conditions. Its pipeline includes several promising drug candidates at various stages of clinical testing, targeting diseases such as rheumatoid arthritis, psoriasis, celiac disease, and certain cancers. The company works alongside partners GSK and Vanda to advance its research programs from early discovery through clinical development.
